PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"34500451","Parkinson's Disease and Gut Microbiota","Hirayama M, Ohno K.","Ann Nutr Metab. 2021;77 Suppl 2:28-35. doi: 10.1159/000518147. Epub 2021 Sep 9.","Hirayama M","Ann Nutr Metab","2021","2021/09/09","","","10.1159/000518147"
"34450312","The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, Poleszak E, Fichna J, Wlaź P.","Pharmacol Res. 2021 Oct;172:105840. doi: 10.1016/j.phrs.2021.105840. Epub 2021 Aug 24.","Socała K","Pharmacol Res","2021","2021/08/27","","","10.1016/j.phrs.2021.105840"
"34784980","Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis","Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D.","Microbiome. 2021 Nov 17;9(1):226. doi: 10.1186/s40168-021-01107-9.","Zhao Z","Microbiome","2021","2021/11/17","PMC8597301","","10.1186/s40168-021-01107-9"
"34205336","Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders","Chen Y, Xu J, Chen Y.","Nutrients. 2021 Jun 19;13(6):2099. doi: 10.3390/nu13062099.","Chen Y","Nutrients","2021","2021/07/02","PMC8234057","","10.3390/nu13062099"
"34942539","The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review","Barrio C, Arias-Sánchez S, Martín-Monzón I.","Psychoneuroendocrinology. 2022 Mar;137:105640. doi: 10.1016/j.psyneuen.2021.105640. Epub 2021 Dec 17.","Barrio C","Psychoneuroendocrinology","2022","2021/12/23","","","10.1016/j.psyneuen.2021.105640"
"32667590","The role of the microbiota-gut-brain axis in neuropsychiatric disorders","Generoso JS, Giridharan VV, Lee J, Macedo D, Barichello T.","Braz J Psychiatry. 2021 May-Jun;43(3):293-305. doi: 10.1590/1516-4446-2020-0987.","Generoso JS","Braz J Psychiatry","2021","2020/07/16","PMC8136391","","10.1590/1516-4446-2020-0987"
"33881598","Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation","Metta V, Leta V, Mrudula KR, Prashanth LK, Goyal V, Borgohain R, Chung-Faye G, Chaudhuri KR.","J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21.","Metta V","J Neurol","2022","2021/04/21","","","10.1007/s00415-021-10567-w"
"34053243","Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy","Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W.","ASN Neuro. 2021 Jan-Dec;13:17590914211016217. doi: 10.1177/17590914211016217.","Kang Y","ASN Neuro","2021","2021/05/31","PMC8165863","","10.1177/17590914211016217"
"33905953","Potential roles of gut microbiota and microbial metabolites in Parkinson's disease","Zheng SY, Li HX, Xu RC, Miao WT, Dai MY, Ding ST, Liu HD.","Ageing Res Rev. 2021 Aug;69:101347. doi: 10.1016/j.arr.2021.101347. Epub 2021 Apr 24.","Zheng SY","Ageing Res Rev","2021","2021/04/27","","","10.1016/j.arr.2021.101347"
"33557896","Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease","Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, Hertzberg V, Auvinen P, Tansey MG, Scheperjans F.","Mol Neurodegener. 2021 Feb 8;16(1):6. doi: 10.1186/s13024-021-00427-6.","Aho VTE","Mol Neurodegener","2021","2021/02/09","PMC7869249","","10.1186/s13024-021-00427-6"
"34707612","Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics","Ding M, Lang Y, Shu H, Shao J, Cui L.","Front Immunol. 2021 Oct 11;12:742449. doi: 10.3389/fimmu.2021.742449. eCollection 2021.","Ding M","Front Immunol","2021","2021/10/28","PMC8542678","","10.3389/fimmu.2021.742449"
"35069178","The Gut-Brain Axis and Its Relation to Parkinson's Disease: A Review","Klann EM, Dissanayake U, Gurrala A, Farrer M, Shukla AW, Ramirez-Zamora A, Mai V, Vedam-Mai V.","Front Aging Neurosci. 2022 Jan 7;13:782082. doi: 10.3389/fnagi.2021.782082. eCollection 2021.","Klann EM","Front Aging Neurosci","2022","2022/01/24","PMC8776990","","10.3389/fnagi.2021.782082"
"35572407","Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection","Shandilya S, Kumar S, Kumar Jha N, Kumar Kesari K, Ruokolainen J.","J Adv Res. 2021 Sep 17;38:223-244. doi: 10.1016/j.jare.2021.09.005. eCollection 2022 May.","Shandilya S","J Adv Res","2021","2022/05/16","PMC9091761","","10.1016/j.jare.2021.09.005"
"34386321","The influence of the gut microbiota on the bioavailability of oral drugs","Zhang X, Han Y, Huang W, Jin M, Gao Z.","Acta Pharm Sin B. 2021 Jul;11(7):1789-1812. doi: 10.1016/j.apsb.2020.09.013. Epub 2020 Sep 28.","Zhang X","Acta Pharm Sin B","2021","2021/08/13","PMC8343123","","10.1016/j.apsb.2020.09.013"
"34576191","The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System","Doroszkiewicz J, Groblewska M, Mroczko B.","Int J Mol Sci. 2021 Sep 17;22(18):10028. doi: 10.3390/ijms221810028.","Doroszkiewicz J","Int J Mol Sci","2021","2021/09/28","PMC8471822","","10.3390/ijms221810028"
"33856024","The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options","Wang Q, Luo Y, Ray Chaudhuri K, Reynolds R, Tan EK, Pettersson S.","Brain. 2021 Oct 22;144(9):2571-2593. doi: 10.1093/brain/awab156.","Wang Q","Brain","2021","2021/04/15","","","10.1093/brain/awab156"
"33623004","Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota","Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, Han P, Peng R, Yu H, Lin Y, Gao TL, Shou JW, Li XY, Zhang XF, Zhang ZW, Fu J, Wen BY, Yu JB, Cao X, Jiang JD.","Signal Transduct Target Ther. 2021 Feb 24;6(1):77. doi: 10.1038/s41392-020-00456-5.","Wang Y","Signal Transduct Target Ther","2021","2021/02/24","PMC7902645","","10.1038/s41392-020-00456-5"
"34695538","Oral, Nasal, and Gut Microbiota in Parkinson's Disease","Li Z, Lu G, Luo E, Wu B, Li Z, Guo J, Xia Z, Zheng C, Su Q, Zeng Y, Chan WY, Su X, Qiu X, Zheng X, Cai Q, Xu Y, Chen Y, Fan Y, Chen W, Yu Z, Chen X, Zheng C, Wang M, Poon WS, Luo X.","Neuroscience. 2022 Jan 1;480:65-78. doi: 10.1016/j.neuroscience.2021.10.011. Epub 2021 Oct 22.","Li Z","Neuroscience","2022","2021/10/25","","","10.1016/j.neuroscience.2021.10.011"
"34492236","Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan","Snigdha S, Ha K, Tsai P, Dinan TG, Bartos JD, Shahid M.","Pharmacol Ther. 2022 Mar;231:107978. doi: 10.1016/j.pharmthera.2021.107978. Epub 2021 Sep 4.","Snigdha S","Pharmacol Ther","2022","2021/09/07","","","10.1016/j.pharmthera.2021.107978"
"33649989","The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease","Dogra N, Mani RJ, Katare DP.","Cell Mol Neurobiol. 2022 Mar;42(2):315-332. doi: 10.1007/s10571-021-01066-7. Epub 2021 Mar 2.","Dogra N","Cell Mol Neurobiol","2022","2021/03/02","","","10.1007/s10571-021-01066-7"
"33417973","Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications","Rani L, Mondal AC.","Neurosci Res. 2021 Jul;168:100-112. doi: 10.1016/j.neures.2021.01.001. Epub 2021 Jan 5.","Rani L","Neurosci Res","2021","2021/01/08","","","10.1016/j.neures.2021.01.001"
"34530073","Alterations of gut microbiota and metabolome with Parkinson's disease","Yan Z, Yang F, Cao J, Ding W, Yan S, Shi W, Wen S, Yao L.","Microb Pathog. 2021 Nov;160:105187. doi: 10.1016/j.micpath.2021.105187. Epub 2021 Sep 13.","Yan Z","Microb Pathog","2021","2021/09/16","","","10.1016/j.micpath.2021.105187"
"33643026","The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis","Shen T, Yue Y, He T, Huang C, Qu B, Lv W, Lai HY.","Front Aging Neurosci. 2021 Feb 12;13:636545. doi: 10.3389/fnagi.2021.636545. eCollection 2021.","Shen T","Front Aging Neurosci","2021","2021/03/01","PMC7907649","","10.3389/fnagi.2021.636545"
"33517890","Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease","Hou YF, Shan C, Zhuang SY, Zhuang QQ, Ghosh A, Zhu KC, Kong XK, Wang SM, Gong YL, Yang YY, Tao B, Sun LH, Zhao HY, Guo XZ, Wang WQ, Ning G, Gu YY, Li ST, Liu JM.","Microbiome. 2021 Jan 31;9(1):34. doi: 10.1186/s40168-020-00988-6.","Hou YF","Microbiome","2021","2021/02/01","PMC7849090","","10.1186/s40168-020-00988-6"
"34536490","Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle","Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM.","Pharmacol Ther. 2022 Mar;231:107988. doi: 10.1016/j.pharmthera.2021.107988. Epub 2021 Sep 16.","Chidambaram SB","Pharmacol Ther","2022","2021/09/18","","","10.1016/j.pharmthera.2021.107988"
"34112355","Zinc","Skalny AV, Aschner M, Tinkov AA.","Adv Food Nutr Res. 2021;96:251-310. doi: 10.1016/bs.afnr.2021.01.003. Epub 2021 May 24.","Skalny AV","Adv Food Nutr Res","2021","2021/06/11","PMC8208231","NIHMS1708141","10.1016/bs.afnr.2021.01.003"
"34589401","Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota-gut-brain axis","Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D.","Acta Pharm Sin B. 2021 Sep;11(9):2859-2879. doi: 10.1016/j.apsb.2021.03.020. Epub 2021 Mar 13.","Zhao Z","Acta Pharm Sin B","2021","2021/09/30","PMC8463266","","10.1016/j.apsb.2021.03.020"
"34669122","An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins","Roe K.","Neurochem Res. 2022 Mar;47(3):517-530. doi: 10.1007/s11064-021-03467-y. Epub 2021 Oct 20.","Roe K","Neurochem Res","2022","2021/10/20","","","10.1007/s11064-021-03467-y"
"33148438","Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway","Sun J, Li H, Jin Y, Yu J, Mao S, Su KP, Ling Z, Liu J.","Brain Behav Immun. 2021 Jan;91:703-715. doi: 10.1016/j.bbi.2020.10.014. Epub 2020 Oct 24.","Sun J","Brain Behav Immun","2021","2020/11/05","","","10.1016/j.bbi.2020.10.014"
"32504503","Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease","Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, Zengin G, Mathew B, Shah MA, Arora S.","Curr Neuropharmacol. 2021;19(2):233-247. doi: 10.2174/1570159X18666200606233050.","Kaur G","Curr Neuropharmacol","2021","2020/06/07","PMC8033978","","10.2174/1570159X18666200606233050"
"34475403","Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson's disease","Yan Y, Ren S, Duan Y, Lu C, Niu Y, Wang Z, Inglis B, Ji W, Zheng Y, Si W.","NPJ Biofilms Microbiomes. 2021 Sep 2;7(1):69. doi: 10.1038/s41522-021-00242-3.","Yan Y","NPJ Biofilms Microbiomes","2021","2021/09/03","PMC8413421","","10.1038/s41522-021-00242-3"
"31684843","Effect of nutrition on neurodegenerative diseases. A systematic review","Bianchi VE, Herrera PF, Laura R.","Nutr Neurosci. 2021 Oct;24(10):810-834. doi: 10.1080/1028415X.2019.1681088. Epub 2019 Nov 4.","Bianchi VE","Nutr Neurosci","2021","2019/11/06","","","10.1080/1028415X.2019.1681088"
"33185912","Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa-carbidopa intrajejunal gel","Melis M, Vascellari S, Santoru ML, Oppo V, Fabbri M, Sarchioto M, Murgia D, Zibetti M, Lopiano L, Serra A, Palmas V, Pisanu S, Perra D, Madau V, Cusano R, Uva P, Mereu A, Contu P, Morelli M, Atzori L, Melis M, Manzin A, Cossu G.","Eur J Neurol. 2021 Apr;28(4):1198-1209. doi: 10.1111/ene.14644. Epub 2020 Dec 16.","Melis M","Eur J Neurol","2021","2020/11/13","","","10.1111/ene.14644"
"34243604","Role of microbiota-derived short-chain fatty acids in nervous system disorders","Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, Zamani F, Yousefimashouf R, Karampoor S.","Biomed Pharmacother. 2021 Jul;139:111661. doi: 10.1016/j.biopha.2021.111661. Epub 2021 May 8.","Mirzaei R","Biomed Pharmacother","2021","2021/07/10","","","10.1016/j.biopha.2021.111661"
"34371014","The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport","Nielsen SD, Pearson NM, Seidler K.","Brain Res. 2021 Oct 15;1769:147609. doi: 10.1016/j.brainres.2021.147609. Epub 2021 Aug 8.","Nielsen SD","Brain Res","2021","2021/08/09","","","10.1016/j.brainres.2021.147609"
"34948234","Human Gut Microbiota in Health and Selected Cancers","Sędzikowska A, Szablewski L.","Int J Mol Sci. 2021 Dec 14;22(24):13440. doi: 10.3390/ijms222413440.","Sędzikowska A","Int J Mol Sci","2021","2021/12/24","PMC8708499","","10.3390/ijms222413440"
"33499229","Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes","Vascellari S, Melis M, Palmas V, Pisanu S, Serra A, Perra D, Santoru ML, Oppo V, Cusano R, Uva P, Atzori L, Morelli M, Cossu G, Manzin A.","Biomolecules. 2021 Jan 22;11(2):144. doi: 10.3390/biom11020144.","Vascellari S","Biomolecules","2021","2021/01/27","PMC7911638","","10.3390/biom11020144"
"34835406","Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease","Sun P, Su L, Zhu H, Li X, Guo Y, Du X, Zhang L, Qin C.","Microorganisms. 2021 Nov 2;9(11):2281. doi: 10.3390/microorganisms9112281.","Sun P","Microorganisms","2021","2021/11/27","PMC8621510","","10.3390/microorganisms9112281"
"34954497","Altered gut microbiota in Parkinson's disease patients with motor complications","Takahashi K, Nishiwaki H, Ito M, Iwaoka K, Takahashi K, Suzuki Y, Taguchi K, Yamahara K, Tsuboi Y, Kashihara K, Hirayama M, Ohno K, Maeda T.","Parkinsonism Relat Disord. 2022 Feb;95:11-17. doi: 10.1016/j.parkreldis.2021.12.012. Epub 2021 Dec 21.","Takahashi K","Parkinsonism Relat Disord","2022","2021/12/26","","","10.1016/j.parkreldis.2021.12.012"
"35052575","Parkinson's Disease and the Metal-Microbiome-Gut-Brain Axis: A Systems Toxicology Approach","Forero-Rodríguez LJ, Josephs-Spaulding J, Flor S, Pinzón A, Kaleta C.","Antioxidants (Basel). 2021 Dec 28;11(1):71. doi: 10.3390/antiox11010071.","Forero-Rodríguez LJ","Antioxidants (Basel)","2021","2022/01/21","PMC8773335","","10.3390/antiox11010071"
"34938619","Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?","Balan Y, Gaur A, Sakthivadivel V, Kamble B, Sundaramurthy R.","Cureus. 2021 Nov 19;13(11):e19740. doi: 10.7759/cureus.19740. eCollection 2021 Nov.","Balan Y","Cureus","2021","2021/12/23","PMC8684598","","10.7759/cureus.19740"
"33352217","Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases","Chen Z, Maqbool J, Sajid F, Hussain G, Sun T.","Microb Pathog. 2021 Jan;150:104675. doi: 10.1016/j.micpath.2020.104675. Epub 2020 Dec 24.","Chen Z","Microb Pathog","2021","2020/12/22","","","10.1016/j.micpath.2020.104675"
"33860738","The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance","Menozzi E, Macnaughtan J, Schapira AHV.","Ann Med. 2021 Dec;53(1):611-625. doi: 10.1080/07853890.2021.1890330.","Menozzi E","Ann Med","2021","2021/04/16","PMC8078923","","10.1080/07853890.2021.1890330"
"33459114","Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease","Bhattarai Y, Si J, Pu M, Ross OA, McLean PJ, Till L, Moor W, Grover M, Kandimalla KK, Margolis KG, Farrugia G, Kashyap PC.","Gut Microbes. 2021 Jan 1;13(1):1866974. doi: 10.1080/19490976.2020.1866974.","Bhattarai Y","Gut Microbes","2021","2021/01/18","PMC7833732","","10.1080/19490976.2020.1866974"
"35779869","Role of the gut microbiota in the development of various neurological diseases","Castillo-Álvarez F, Marzo-Sola ME.","Neurologia (Engl Ed). 2022 Jul-Aug;37(6):492-498. doi: 10.1016/j.nrleng.2019.03.026. Epub 2021 May 25.","Castillo-Álvarez F","Neurologia (Engl Ed)","2022","2022/07/02","","","10.1016/j.nrleng.2019.03.026"
"34274348","Interactions between the microbiota and enteric nervous system during gut-brain disorders","Fried S, Wemelle E, Cani PD, Knauf C.","Neuropharmacology. 2021 Oct 1;197:108721. doi: 10.1016/j.neuropharm.2021.108721. Epub 2021 Jul 15.","Fried S","Neuropharmacology","2021","2021/07/18","","","10.1016/j.neuropharm.2021.108721"
"33279302","Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases","Konjevod M, Nikolac Perkovic M, Sáiz J, Svob Strac D, Barbas C, Rojo D.","J Pharm Biomed Anal. 2021 Feb 5;194:113681. doi: 10.1016/j.jpba.2020.113681. Epub 2020 Nov 21.","Konjevod M","J Pharm Biomed Anal","2021","2020/12/06","","","10.1016/j.jpba.2020.113681"
"33573273","Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis","Grüner N, Mattner J.","Int J Mol Sci. 2021 Jan 30;22(3):1397. doi: 10.3390/ijms22031397.","Grüner N","Int J Mol Sci","2021","2021/02/12","PMC7866539","","10.3390/ijms22031397"
"34571840","Helicobacter pylori Infection and Extragastric Diseases-A Focus on the Central Nervous System","Baj J, Forma A, Flieger W, Morawska I, Michalski A, Buszewicz G, Sitarz E, Portincasa P, Garruti G, Flieger M, Teresiński G.","Cells. 2021 Aug 25;10(9):2191. doi: 10.3390/cells10092191.","Baj J","Cells","2021","2021/09/28","PMC8469861","","10.3390/cells10092191"
"34370175","Gut brain axis: an insight into microbiota role in Parkinson's disease","Moustafa SA, Mohamed S, Dawood A, Azar J, Elmorsy E, Rizk NAM, Salama M.","Metab Brain Dis. 2021 Oct;36(7):1545-1557. doi: 10.1007/s11011-021-00808-2. Epub 2021 Aug 9.","Moustafa SA","Metab Brain Dis","2021","2021/08/09","","","10.1007/s11011-021-00808-2"
"34884399","Differences in the Composition of Gut Microbiota between Patients with Parkinson's Disease and Healthy Controls: A Cohort Study","Zapała B, Stefura T, Wójcik-Pędziwiatr M, Kabut R, Bałajewicz-Nowak M, Milewicz T, Dudek A, Stój A, Rudzińska-Bar M.","J Clin Med. 2021 Dec 3;10(23):5698. doi: 10.3390/jcm10235698.","Zapała B","J Clin Med","2021","2021/12/10","PMC8658639","","10.3390/jcm10235698"
"34829694","Probiotic Enhancement of Antioxidant Capacity and Alterations of Gut Microbiota Composition in 6-Hydroxydopamin-Induced Parkinson's Disease Rats","Tsao SP, Nurrahma BA, Kumar R, Wu CH, Yeh TH, Chiu CC, Lee YP, Liao YC, Huang CH, Yeh YT, Huang HY.","Antioxidants (Basel). 2021 Nov 17;10(11):1823. doi: 10.3390/antiox10111823.","Tsao SP","Antioxidants (Basel)","2021","2021/11/27","PMC8615185","","10.3390/antiox10111823"
"34839011","Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial","Becker A, Schmartz GP, Gröger L, Grammes N, Galata V, Philippeit H, Weiland J, Ludwig N, Meese E, Tierling S, Walter J, Schwiertz A, Spiegel J, Wagenpfeil G, Faßbender K, Keller A, Unger MM.","Genomics Proteomics Bioinformatics. 2022 Apr;20(2):274-287. doi: 10.1016/j.gpb.2021.08.009. Epub 2021 Nov 25.","Becker A","Genomics Proteomics Bioinformatics","2022","2021/11/28","PMC9684155","","10.1016/j.gpb.2021.08.009"
"34358037","Modulation of Neuroinflammation by the Gut Microbiota in Prion and Prion-Like Diseases","Trichka J, Zou WQ.","Pathogens. 2021 Jul 13;10(7):887. doi: 10.3390/pathogens10070887.","Trichka J","Pathogens","2021","2021/08/06","PMC8308761","","10.3390/pathogens10070887"
"34216356","The Relationship Between the Gut Microbiome and Neurodegenerative Diseases","Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, Yuan Y, Li L.","Neurosci Bull. 2021 Oct;37(10):1510-1522. doi: 10.1007/s12264-021-00730-8. Epub 2021 Jul 3.","Zhu X","Neurosci Bull","2021","2021/07/03","PMC8490573","","10.1007/s12264-021-00730-8"
"33428888","Gut microbiota-derived vitamins - underrated powers of a multipotent ally in psychiatric health and disease","Rudzki L, Stone TW, Maes M, Misiak B, Samochowiec J, Szulc A.","Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20;107:110240. doi: 10.1016/j.pnpbp.2020.110240. Epub 2021 Jan 9.","Rudzki L","Prog Neuropsychopharmacol Biol Psychiatry","2021","2021/01/11","","","10.1016/j.pnpbp.2020.110240"
"33825149","Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment","Liang Y, Cui L, Gao J, Zhu M, Zhang Y, Zhang HL.","Mol Neurobiol. 2021 Aug;58(8):3745-3758. doi: 10.1007/s12035-021-02375-0. Epub 2021 Apr 6.","Liang Y","Mol Neurobiol","2021","2021/04/07","PMC8280023","","10.1007/s12035-021-02375-0"
"34682763","The Microbiota-Gut-Brain Axis as a Key to Neuropsychiatric Disorders: A Mini Review","Stopińska K, Radziwoń-Zaleska M, Domitrz I.","J Clin Med. 2021 Oct 10;10(20):4640. doi: 10.3390/jcm10204640.","Stopińska K","J Clin Med","2021","2021/10/23","PMC8539144","","10.3390/jcm10204640"
"34440599","The Role of Gut Microbiota in Aging and Aging Related Neurodegenerative Disorders: Insights from Drosophila Model","Kong Y, Wang L, Jiang B.","Life (Basel). 2021 Aug 20;11(8):855. doi: 10.3390/life11080855.","Kong Y","Life (Basel)","2021","2021/08/27","PMC8399269","","10.3390/life11080855"
"33406628","Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease","Li P, Killinger BA, Ensink E, Beddows I, Yilmaz A, Lubben N, Lamp J, Schilthuis M, Vega IE, Woltjer R, Pospisilik JA, Brundin P, Brundin L, Graham SF, Labrie V.","Metabolites. 2021 Jan 4;11(1):29. doi: 10.3390/metabo11010029.","Li P","Metabolites","2021","2021/01/07","PMC7823437","","10.3390/metabo11010029"
"34737076","Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis","Johnson AM, Ou ZA, Gordon R, Saminathan H.","Int J Biochem Cell Biol. 2022 Jan;142:106113. doi: 10.1016/j.biocel.2021.106113. Epub 2021 Nov 2.","Johnson AM","Int J Biochem Cell Biol","2022","2021/11/05","","","10.1016/j.biocel.2021.106113"
"34512244","What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?","Hill AE, Wade-Martins R, Burnet PWJ.","Front Neurosci. 2021 Aug 26;15:708587. doi: 10.3389/fnins.2021.708587. eCollection 2021.","Hill AE","Front Neurosci","2021","2021/09/13","PMC8432298","","10.3389/fnins.2021.708587"
"34094829","Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson's disease treatment","Shang J, Ma S, Zang C, Bao X, Wang Y, Zhang D.","Acta Pharm Sin B. 2021 May;11(5):1213-1226. doi: 10.1016/j.apsb.2021.01.009. Epub 2021 Jan 26.","Shang J","Acta Pharm Sin B","2021","2021/06/07","PMC8148066","","10.1016/j.apsb.2021.01.009"
"34977556","Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease","Ghyselinck J, Verstrepen L, Moens F, Van Den Abbeele P, Bruggeman A, Said J, Smith B, Barker LA, Jordan C, Leta V, Chaudhuri KR, Basit AW, Gaisford S.","Int J Pharm X. 2021 Jul 2;3:100087. doi: 10.1016/j.ijpx.2021.100087. eCollection 2021 Dec.","Ghyselinck J","Int J Pharm X","2021","2022/01/03","PMC8683682","","10.1016/j.ijpx.2021.100087"
"35111696","Gut Microbiota: A Key Regulator in the Effects of Environmental Hazards on Modulates Insulin Resistance","Huang R.","Front Cell Infect Microbiol. 2022 Jan 17;11:800432. doi: 10.3389/fcimb.2021.800432. eCollection 2021.","Huang R","Front Cell Infect Microbiol","2022","2022/02/03","PMC8801599","","10.3389/fcimb.2021.800432"
"33804226","New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota","Lorente-Picón M, Laguna A.","Biomolecules. 2021 Mar 15;11(3):433. doi: 10.3390/biom11030433.","Lorente-Picón M","Biomolecules","2021","2021/04/03","PMC7998286","","10.3390/biom11030433"
"33857347","Bacterial Extracellular Vesicles and the Gut-Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics","Pirolli NH, Bentley WE, Jay SM.","Adv Biol (Weinh). 2021 Jul;5(7):e2000540. doi: 10.1002/adbi.202000540. Epub 2021 Apr 15.","Pirolli NH","Adv Biol (Weinh)","2021","2021/04/15","","","10.1002/adbi.202000540"
"33746867","Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease","Palacios N, Hannoun A, Flahive J, Ward D, Goostrey K, Deb A, Smith KM.","Front Neurol. 2021 Mar 4;12:574529. doi: 10.3389/fneur.2021.574529. eCollection 2021.","Palacios N","Front Neurol","2021","2021/03/22","PMC7970035","","10.3389/fneur.2021.574529"
"34934429","Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons","Zhang T, Wang T, Chen X, Zhao Z, Chen Z.","Exp Ther Med. 2022 Jan;23(1):52. doi: 10.3892/etm.2021.10974. Epub 2021 Nov 16.","Zhang T","Exp Ther Med","2022","2021/12/22","PMC8652398","","10.3892/etm.2021.10974"
"33763767","Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics","Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK.","Arch Microbiol. 2021 Aug;203(6):2895-2910. doi: 10.1007/s00203-021-02276-9. Epub 2021 Mar 24.","Banerjee A","Arch Microbiol","2021","2021/03/25","","","10.1007/s00203-021-02276-9"
"33337387","Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients","Cilia R, Piatti M, Cereda E, Bolliri C, Caronni S, Ferri V, Cassani E, Bonvegna S, Ferrarese C, Zecchinelli AL, Barichella M, Pezzoli G.","J Parkinsons Dis. 2021;11(1):159-170. doi: 10.3233/JPD-202297.","Cilia R","J Parkinsons Dis","2021","2020/12/18","","","10.3233/JPD-202297"
"33418492","Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease","Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, Yun M, Lee SG, Lee PH.","Nutrition. 2021 Mar;83:111090. doi: 10.1016/j.nut.2020.111090. Epub 2020 Nov 21.","Chung SJ","Nutrition","2021","2021/01/08","","","10.1016/j.nut.2020.111090"
"34219519","The Role of The Gut Microbiome in Parkinson's Disease","Gallop A, Weagley J, Paracha SU, Grossberg G.","J Geriatr Psychiatry Neurol. 2021 Jul;34(4):253-262. doi: 10.1177/08919887211018268.","Gallop A","J Geriatr Psychiatry Neurol","2021","2021/07/05","","","10.1177/08919887211018268"
"34032644","Gut Microbiota as a Mediator of Host Neuro-Immune Interactions: Implications in Neuroinflammatory Disorders","Caputi V, Popov J, Giron MC, O Apos Mahony S.","Mod Trends Psychiatry. 2021;32:40-57. doi: 10.1159/000510416. Epub 2021 May 6.","Caputi V","Mod Trends Psychiatry","2021","2021/05/25","","","10.1159/000510416"
"33510784","Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain","Xu HM, Huang HL, Zhou YL, Zhao HL, Xu J, Shou DW, Liu YD, Zhou YJ, Nie YQ.","Gastroenterol Res Pract. 2021 Jan 16;2021:6699268. doi: 10.1155/2021/6699268. eCollection 2021.","Xu HM","Gastroenterol Res Pract","2021","2021/01/29","PMC7826222","","10.1155/2021/6699268"
"34473437","Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting?","Mazzini L, De Marchi F, Niccolai E, Mandrioli J, Amedei A.","In: Araki T, editor. Amyotrophic Lateral Sclerosis [Internet]. Brisbane (AU): Exon Publications; 2021 Jul 25. Chapter 8.","Mazzini L","Amyotrophic Lateral Sclerosis","2021","2021/07/25","","","10.36255/exonpublications.amyotrophiclateralsclerosis.microbiota.2021"
"34360787","Parkinson's Disease: A Prionopathy?","Vascellari S, Manzin A.","Int J Mol Sci. 2021 Jul 27;22(15):8022. doi: 10.3390/ijms22158022.","Vascellari S","Int J Mol Sci","2021","2021/08/07","PMC8347681","","10.3390/ijms22158022"
"33400024","Is Gut Dysbiosis an Epicenter of Parkinson's Disease?","Rajput C, Sarkar A, Sachan N, Rawat N, Singh MP.","Neurochem Res. 2021 Mar;46(3):425-438. doi: 10.1007/s11064-020-03187-9. Epub 2021 Jan 5.","Rajput C","Neurochem Res","2021","2021/01/05","","","10.1007/s11064-020-03187-9"
"34381040","Genetic and environmental factors in Alzheimer's and Parkinson's diseases and promising therapeutic intervention via fecal microbiota transplantation","Wang H, Yang F, Zhang S, Xin R, Sun Y.","NPJ Parkinsons Dis. 2021 Aug 11;7(1):70. doi: 10.1038/s41531-021-00213-7.","Wang H","NPJ Parkinsons Dis","2021","2021/08/12","PMC8357954","","10.1038/s41531-021-00213-7"
"33262001","Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease","Giron MC, Mazzi U.","Nucl Med Biol. 2021 Jan;92:72-77. doi: 10.1016/j.nucmedbio.2020.11.002. Epub 2020 Nov 19.","Giron MC","Nucl Med Biol","2021","2020/12/02","","","10.1016/j.nucmedbio.2020.11.002"
"33338469","Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide","Bhattacharyya D, Bhunia A.","Chem Phys Lipids. 2021 Mar;235:105029. doi: 10.1016/j.chemphyslip.2020.105029. Epub 2020 Dec 15.","Bhattacharyya D","Chem Phys Lipids","2021","2020/12/18","","","10.1016/j.chemphyslip.2020.105029"
"33549028","A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics","Yang H, Liu Y, Cai R, Li Y, Gu B.","Ann Palliat Med. 2021 Feb;10(2):2304-2313. doi: 10.21037/apm-20-1365. Epub 2021 Jan 28.","Yang H","Ann Palliat Med","2021","2021/02/07","","","10.21037/apm-20-1365"
"34357086","Microbiota Gut-Brain Axis in Ischemic Stroke: A Narrative Review with a Focus about the Relationship with Inflammatory Bowel Disease","Sinagra E, Pellegatta G, Guarnotta V, Maida M, Rossi F, Conoscenti G, Pallio S, Alloro R, Raimondo D, Pace F, Anderloni A.","Life (Basel). 2021 Jul 19;11(7):715. doi: 10.3390/life11070715.","Sinagra E","Life (Basel)","2021","2021/08/06","PMC8305026","","10.3390/life11070715"
"34346706","Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia","Ma L, Keng J, Cheng M, Pan H, Feng B, Hu Y, Feng T, Yang F.","mSphere. 2021 Aug 25;6(4):e0028321. doi: 10.1128/mSphere.00283-21. Epub 2021 Aug 4.","Ma L","mSphere","2021","2021/08/04","PMC8386414","","10.1128/mSphere.00283-21"
"33470765","The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway","Huang T, Shi H, Xu Y, Ji L.","Neuroreport. 2021 Feb 3;32(3):244-251. doi: 10.1097/WNR.0000000000001585.","Huang T","Neuroreport","2021","2021/01/20","","","10.1097/WNR.0000000000001585"
"33488420","Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019","Zhu X, Hu J, Deng S, Tan Y, Qiu C, Zhang M, Ni X, Lu H, Wang Z, Li L, Chen H, Huang S, Xiao T, Shang D, Wen Y.","Front Psychiatry. 2021 Jan 8;11:587670. doi: 10.3389/fpsyt.2020.587670. eCollection 2020.","Zhu X","Front Psychiatry","2021","2021/01/25","PMC7819979","","10.3389/fpsyt.2020.587670"
"34495955","Gut microbiota alterations in response to sleep length among African-origin adults","Fei N, Choo-Kang C, Reutrakul S, Crowley SJ, Rae D, Bedu-Addo K, Plange-Rhule J, Forrester TE, Lambert EV, Bovet P, Riesen W, Korte W, Luke A, Layden BT, Gilbert JA, Dugas LR.","PLoS One. 2021 Sep 8;16(9):e0255323. doi: 10.1371/journal.pone.0255323. eCollection 2021.","Fei N","PLoS One","2021","2021/09/08","PMC8425534","","10.1371/journal.pone.0255323"
"34974121","Gut microbiota modulation by prednisolone in a rat kindling model of pentylenetetrazol (PTZ)-induced seizure","de Lima AMDL, de Lima Rosa G, Müller Guzzo EF, Padilha RB, Costa da Silva R, Silveira AK, de Lima Morales D, Conci de Araujo M, Fonseca Moreira JC, Barth AL, Coitinho AS, Van Der Sand ST.","Microb Pathog. 2022 Feb;163:105376. doi: 10.1016/j.micpath.2021.105376. Epub 2021 Dec 30.","de Lima AMDL","Microb Pathog","2022","2022/01/02","","","10.1016/j.micpath.2021.105376"
"36072680","Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome","Thomas A, Thomas A, Butler-Sanchez M.","Am J Lifestyle Med. 2021 May 10;16(5):608-621. doi: 10.1177/15598276211012968. eCollection 2022 Sep-Oct.","Thomas A","Am J Lifestyle Med","2021","2022/09/08","PMC9442469","","10.1177/15598276211012968"
"34776854","Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson's Disease Cohort","Kenna JE, Chua EG, Bakeberg M, Tay A, McGregor S, Gorecki A, Horne M, Marshall B, Mastaglia FL, Anderton RS.","Front Neurosci. 2021 Oct 29;15:756951. doi: 10.3389/fnins.2021.756951. eCollection 2021.","Kenna JE","Front Neurosci","2021","2021/11/15","PMC8588830","","10.3389/fnins.2021.756951"
"34560239","Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome","Shan J, Qu Y, Wang S, Wei Y, Chang L, Ma L, Hashimoto K.","Brain Res Bull. 2021 Dec;177:103-110. doi: 10.1016/j.brainresbull.2021.09.009. Epub 2021 Sep 22.","Shan J","Brain Res Bull","2021","2021/09/24","","","10.1016/j.brainresbull.2021.09.009"
"34908715","Gut-brain axis: Synergistic approach","Sharma M, Prakash J, Yadav P, Srivastava K, Chatterjee K.","Ind Psychiatry J. 2021 Oct;30(Suppl 1):S297-S300. doi: 10.4103/0972-6748.328835. Epub 2021 Oct 22.","Sharma M","Ind Psychiatry J","2021","2021/12/15","PMC8611583","","10.4103/0972-6748.328835"
"34893951","Potential Role of Akkermansia muciniphila in Parkinson's Disease and Other Neurological/Autoimmune Diseases","Fang X, Li FJ, Hong DJ.","Curr Med Sci. 2021 Dec;41(6):1172-1177. doi: 10.1007/s11596-021-2464-5. Epub 2021 Dec 10.","Fang X","Curr Med Sci","2021","2021/12/11","","","10.1007/s11596-021-2464-5"
"33404072","Role of pattern recognition receptors and the microbiota in neurological disorders","Keogh CE, Rude KM, Gareau MG.","J Physiol. 2021 Mar;599(5):1379-1389. doi: 10.1113/JP279771. Epub 2021 Jan 13.","Keogh CE","J Physiol","2021","2021/01/06","PMC8221416","NIHMS1713016","10.1113/JP279771"
"33985520","Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation","Kuai XY, Yao XH, Xu LJ, Zhou YQ, Zhang LP, Liu Y, Pei SF, Zhou CL.","Microb Cell Fact. 2021 May 13;20(1):98. doi: 10.1186/s12934-021-01589-0.","Kuai XY","Microb Cell Fact","2021","2021/05/14","PMC8120701","","10.1186/s12934-021-01589-0"
"33657381","Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease","Rosario D, Bidkhori G, Lee S, Bedarf J, Hildebrand F, Le Chatelier E, Uhlen M, Ehrlich SD, Proctor G, Wüllner U, Mardinoglu A, Shoaie S.","Cell Rep. 2021 Mar 2;34(9):108807. doi: 10.1016/j.celrep.2021.108807.","Rosario D","Cell Rep","2021","2021/03/03","","","10.1016/j.celrep.2021.108807"
"34053222","Development of an Efficient and Sensitive Chemical Derivatization-Based LC-MS/MS Method for Quantifying Gut Microbiota-Derived Metabolites in Human Plasma and Its Application in Studying Cardiovascular Disease","Liao HY, Wang CY, Lee CH, Kao HL, Wu WK, Kuo CH.","J Proteome Res. 2021 Jul 2;20(7):3508-3518. doi: 10.1021/acs.jproteome.1c00147. Epub 2021 May 31.","Liao HY","J Proteome Res","2021","2021/05/31","","","10.1021/acs.jproteome.1c00147"
"32865266","Leveraging sequence-based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson's disease","Ji T, Huang H, Liu J, Peng T, Zhou X, Tan Q, Yuan J, Hua H, Ding S, Liu H.","Eur J Neurosci. 2021 Jan;53(2):687-696. doi: 10.1111/ejn.14952. Epub 2020 Sep 15.","Ji T","Eur J Neurosci","2021","2020/09/01","","","10.1111/ejn.14952"
"34276644","Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson's Disease","Li Z, Lu G, Li Z, Wu B, Luo E, Qiu X, Guo J, Xia Z, Zheng C, Su Q, Zeng Y, Chan WY, Su X, Cai Q, Xu Y, Chen Y, Wang M, Poon WS, Luo X.","Front Immunol. 2021 Jul 2;12:632482. doi: 10.3389/fimmu.2021.632482. eCollection 2021.","Li Z","Front Immunol","2021","2021/07/19","PMC8284394","","10.3389/fimmu.2021.632482"
"33633723","Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori","Gorlé N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE.","Front Immunol. 2021 Jan 28;11:584165. doi: 10.3389/fimmu.2020.584165. eCollection 2020.","Gorlé N","Front Immunol","2021","2021/02/26","PMC7901999","","10.3389/fimmu.2020.584165"
"33692356","Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation","Romano S, Savva GM, Bedarf JR, Charles IG, Hildebrand F, Narbad A.","NPJ Parkinsons Dis. 2021 Mar 10;7(1):27. doi: 10.1038/s41531-021-00156-z.","Romano S","NPJ Parkinsons Dis","2021","2021/03/11","PMC7946946","","10.1038/s41531-021-00156-z"
"33912026","Colonic Dopaminergic Neurons Changed Reversely With Those in the Midbrain via Gut Microbiota-Mediated Autophagy in a Chronic Parkinson's Disease Mice Model","Liu X, Du ZR, Wang X, Luk KH, Chan CH, Cao X, Zhao Q, Zhao F, Wong WT, Wong KH, Dong XL.","Front Aging Neurosci. 2021 Apr 12;13:649627. doi: 10.3389/fnagi.2021.649627. eCollection 2021.","Liu X","Front Aging Neurosci","2021","2021/04/29","PMC8071868","","10.3389/fnagi.2021.649627"
"33557583","Electroacupuncture may alleviate behavioral defects via modulation of gut microbiota in a mouse model of Parkinson's disease","Han QQ, Fu Y, Le JM, Pilot A, Cheng S, Chen PQ, Wu H, Wan GQ, Gu XF.","Acupunct Med. 2021 Oct;39(5):501-511. doi: 10.1177/0964528421990658. Epub 2021 Feb 8.","Han QQ","Acupunct Med","2021","2021/02/09","","","10.1177/0964528421990658"
"34569965","Drosophila as a Model for Microbiota Studies of Neurodegeneration","Kitani-Morii F, Friedland RP, Yoshida H, Mizuno T.","J Alzheimers Dis. 2021;84(2):479-490. doi: 10.3233/JAD-215031.","Kitani-Morii F","J Alzheimers Dis","2021","2021/09/27","PMC8673522","","10.3233/JAD-215031"
"33889128","Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota","Li C, Hou Y, Wang X, Li YX, Li F, Zhang C, Li WG.","Front Neurol. 2021 Apr 6;12:653833. doi: 10.3389/fneur.2021.653833. eCollection 2021.","Li C","Front Neurol","2021","2021/04/23","PMC8056012","","10.3389/fneur.2021.653833"
"34128115","The impact of device-assisted therapies on the gut microbiome in Parkinson's disease","Lubomski M, Xu X, Holmes AJ, Yang JYH, Sue CM, Davis RL.","J Neurol. 2022 Feb;269(2):780-795. doi: 10.1007/s00415-021-10657-9. Epub 2021 Jun 15.","Lubomski M","J Neurol","2022","2021/06/15","","","10.1007/s00415-021-10657-9"
"33719004","Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease","Liu X, Liu S, Tang Y, Pu Z, Xiao H, Gao J, Yin Q, Jia Y, Bai Q.","Neurochem Res. 2021 Jun;46(6):1514-1539. doi: 10.1007/s11064-021-03293-2. Epub 2021 Mar 15.","Liu X","Neurochem Res","2021","2021/03/15","","","10.1007/s11064-021-03293-2"
"34171417","The neuromicrobiology of Parkinson's disease: A unifying theory","Munoz-Pinto MF, Empadinhas N, Cardoso SM.","Ageing Res Rev. 2021 Sep;70:101396. doi: 10.1016/j.arr.2021.101396. Epub 2021 Jun 23.","Munoz-Pinto MF","Ageing Res Rev","2021","2021/06/25","","","10.1016/j.arr.2021.101396"
"34652580","Introduction to the Special Issue ""The Brain-Gut Axis""","Taché Y, Saavedra JM.","Cell Mol Neurobiol. 2022 Mar;42(2):311-313. doi: 10.1007/s10571-021-01155-7. Epub 2021 Oct 15.","Taché Y","Cell Mol Neurobiol","2022","2021/10/15","","","10.1007/s10571-021-01155-7"
"34785689","Cholecystectomy and subsequent risk of Parkinson's disease: a nationwide retrospective cohort study","Kim R, Lee JY, Park S, Han K, Shin CM.","NPJ Parkinsons Dis. 2021 Nov 16;7(1):100. doi: 10.1038/s41531-021-00245-z.","Kim R","NPJ Parkinsons Dis","2021","2021/11/17","PMC8595409","","10.1038/s41531-021-00245-z"
"33070123","A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective","Rawat K, Singh N, Kumari P, Saha L.","Rev Neurosci. 2020 Oct 19;32(2):143-157. doi: 10.1515/revneuro-2020-0078. Print 2021 Feb 23.","Rawat K","Rev Neurosci","2020","2020/10/18","","","10.1515/revneuro-2020-0078"
"34430117","Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease","Nandwana V, Debbarma S.","Cureus. 2021 Jul 20;13(7):e16503. doi: 10.7759/cureus.16503. eCollection 2021 Jul.","Nandwana V","Cureus","2021","2021/08/25","PMC8374998","","10.7759/cureus.16503"
"34422879","Memorable Food: Fighting Age-Related Neurodegeneration by Precision Nutrition","Milošević M, Arsić A, Cvetković Z, Vučić V.","Front Nutr. 2021 Aug 5;8:688086. doi: 10.3389/fnut.2021.688086. eCollection 2021.","Milošević M","Front Nutr","2021","2021/08/23","PMC8374314","","10.3389/fnut.2021.688086"
"34566874","Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease","Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R.","Front Neurol. 2021 Sep 10;12:729961. doi: 10.3389/fneur.2021.729961. eCollection 2021.","Baizabal-Carvallo JF","Front Neurol","2021","2021/09/27","PMC8461169","","10.3389/fneur.2021.729961"
"33803607","Fermented Soy Products: Beneficial Potential in Neurodegenerative Diseases","Jang CH, Oh J, Lim JS, Kim HJ, Kim JS.","Foods. 2021 Mar 18;10(3):636. doi: 10.3390/foods10030636.","Jang CH","Foods","2021","2021/04/03","PMC8003083","","10.3390/foods10030636"
"34836918","Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria","Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalhães JD, Pereira-Santos AR, Ferreira IL, Alarico S, Tiago I, Empadinhas N, Cardoso SM.","Gut. 2023 Jan;72(1):73-89. doi: 10.1136/gutjnl-2021-326023. Epub 2021 Nov 26.","Esteves AR","Gut","2023","2021/11/27","PMC9763194","","10.1136/gutjnl-2021-326023"
"35002935","Mediterranean Diet Adherence in People With Parkinson's Disease Reduces Constipation Symptoms and Changes Fecal Microbiota After a 5-Week Single-Arm Pilot Study","Rusch C, Beke M, Tucciarone L, Nieves C Jr, Ukhanova M, Tagliamonte MS, Mai V, Suh JH, Wang Y, Chiu S, Patel B, Ramirez-Zamora A, Langkamp-Henken B.","Front Neurol. 2021 Dec 23;12:794640. doi: 10.3389/fneur.2021.794640. eCollection 2021.","Rusch C","Front Neurol","2021","2022/01/10","PMC8733603","","10.3389/fneur.2021.794640"
"33154567","Using multi-organ culture systems to study Parkinson's disease","Reiner O, Sapir T, Parichha A.","Mol Psychiatry. 2021 Mar;26(3):725-735. doi: 10.1038/s41380-020-00936-8. Epub 2020 Nov 5.","Reiner O","Mol Psychiatry","2021","2020/11/06","PMC7643717","","10.1038/s41380-020-00936-8"
"34032647","Production of Psychoactive Metabolites by Gut Bacteria","Wiley NC, Cryan JF, Dinan TG, Ross RP, Stanton C.","Mod Trends Psychiatry. 2021;32:74-99. doi: 10.1159/000510419. Epub 2021 May 6.","Wiley NC","Mod Trends Psychiatry","2021","2021/05/25","","","10.1159/000510419"
"34347266","Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein","Zhong Z, Chen W, Gao H, Che N, Xu M, Yang L, Zhang Y, Ye M.","Neurochem Res. 2021 Nov;46(11):3050-3058. doi: 10.1007/s11064-021-03411-0. Epub 2021 Aug 4.","Zhong Z","Neurochem Res","2021","2021/08/04","","","10.1007/s11064-021-03411-0"
"33717189","Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases","Miller AL, Bessho S, Grando K, Tükel Ç.","Front Immunol. 2021 Feb 26;12:638867. doi: 10.3389/fimmu.2021.638867. eCollection 2021.","Miller AL","Front Immunol","2021","2021/03/15","PMC7952436","","10.3389/fimmu.2021.638867"
"34012926","Desulfovibrio Bacteria Are Associated With Parkinson's Disease","Murros KE, Huynh VA, Takala TM, Saris PEJ.","Front Cell Infect Microbiol. 2021 May 3;11:652617. doi: 10.3389/fcimb.2021.652617. eCollection 2021.","Murros KE","Front Cell Infect Microbiol","2021","2021/05/20","PMC8126658","","10.3389/fcimb.2021.652617"
"33327916","Modulation of Gut-Brain Axis by Probiotics: A Promising Anti-depressant Approach","Rajanala K, Kumar N, Chamallamudi MR.","Curr Neuropharmacol. 2021;19(7):990-1006. doi: 10.2174/1570159X19666201215142520.","Rajanala K","Curr Neuropharmacol","2021","2020/12/17","PMC8686316","","10.2174/1570159X19666201215142520"
"33963284","Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","Wei Y, Chang L, Hashimoto K.","Mol Psychiatry. 2022 Jan;27(1):559-573. doi: 10.1038/s41380-021-01121-1. Epub 2021 May 7.","Wei Y","Mol Psychiatry","2022","2021/05/08","PMC8960399","","10.1038/s41380-021-01121-1"
"34795270","Micronutrient supplements can promote disruptive protozoan and fungal communities in the developing infant gut","Popovic A, Bourdon C, Wang PW, Guttman DS, Soofi S, Bhutta ZA, Bandsma RHJ, Parkinson J, Pell LG.","Nat Commun. 2021 Nov 18;12(1):6729. doi: 10.1038/s41467-021-27010-3.","Popovic A","Nat Commun","2021","2021/11/19","PMC8602372","","10.1038/s41467-021-27010-3"
"33704660","Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?","Tiwari RK, Moin A, Rizvi SMD, Shahid SMA, Bajpai P.","Metab Brain Dis. 2021 Jun;36(5):829-847. doi: 10.1007/s11011-021-00696-6. Epub 2021 Mar 11.","Tiwari RK","Metab Brain Dis","2021","2021/03/11","","","10.1007/s11011-021-00696-6"
"34402617","Advances in Genome-Scale Metabolic Modeling toward Microbial Community Analysis of the Human Microbiome","Esvap E, Ulgen KO.","ACS Synth Biol. 2021 Sep 17;10(9):2121-2137. doi: 10.1021/acssynbio.1c00140. Epub 2021 Aug 17.","Esvap E","ACS Synth Biol","2021","2021/08/17","","","10.1021/acssynbio.1c00140"
"34829716","The Emerging Scenario of the Gut-Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases","Pereira TMC, Côco LZ, Ton AMM, Meyrelles SS, Campos-Toimil M, Campagnaro BP, Vasquez EC.","Antioxidants (Basel). 2021 Nov 20;10(11):1845. doi: 10.3390/antiox10111845.","Pereira TMC","Antioxidants (Basel)","2021","2021/11/27","PMC8614795","","10.3390/antiox10111845"
"33166735","Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment","Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G.","Pharmacol Res. 2021 Feb;164:105277. doi: 10.1016/j.phrs.2020.105277. Epub 2020 Nov 7.","Koszewicz M","Pharmacol Res","2021","2020/11/09","","","10.1016/j.phrs.2020.105277"
"34769091","Small Intestinal Bacterial Overgrowth as Potential Therapeutic Target in Parkinson's Disease","Dănău A, Dumitrescu L, Lefter A, Tulbă D, Popescu BO.","Int J Mol Sci. 2021 Oct 28;22(21):11663. doi: 10.3390/ijms222111663.","Dănău A","Int J Mol Sci","2021","2021/11/13","PMC8584211","","10.3390/ijms222111663"
"34909657","Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders","Khatri DK, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S, Singh SB.","Curr Res Pharmacol Drug Discov. 2021 Apr 8;2:100022. doi: 10.1016/j.crphar.2021.100022. eCollection 2021.","Khatri DK","Curr Res Pharmacol Drug Discov","2021","2021/12/15","PMC8663985","","10.1016/j.crphar.2021.100022"
"33571701","The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy","Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.","Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.","Griñán-Ferré C","Ageing Res Rev","2021","2021/02/11","","","10.1016/j.arr.2021.101271"
"33063712","The emerging role of probiotics in neurodegenerative diseases: new hope for Parkinson's disease?","Castelli V, d'Angelo M, Quintiliani M, Benedetti E, Cifone MG, Cimini A.","Neural Regen Res. 2021 Apr;16(4):628-634. doi: 10.4103/1673-5374.295270.","Castelli V","Neural Regen Res","2021","2020/10/16","PMC8067943","","10.4103/1673-5374.295270"
"33417221","Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration","Dolatshahi M, Sabahi M, Aarabi MH.","Mol Neurobiol. 2021 May;58(5):2379-2394. doi: 10.1007/s12035-020-02236-2. Epub 2021 Jan 8.","Dolatshahi M","Mol Neurobiol","2021","2021/01/08","PMC7791539","","10.1007/s12035-020-02236-2"
"35035709","An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation","Chen W, Bi Z, Zhu Q, Gao H, Fan Y, Zhang C, Liu X, Ye M.","Am J Transl Res. 2021 Dec 15;13(12):13710-13722. eCollection 2021.","Chen W","Am J Transl Res","2021","2022/01/17","PMC8748098","",""
"33935107","Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson's Disease","He X, Qian Y, Xu S, Zhang Y, Mo C, Guo W, Yang X, Xiao Q.","J Parkinsons Dis. 2021;11(3):1167-1176. doi: 10.3233/JPD-212604.","He X","J Parkinsons Dis","2021","2021/05/03","","","10.3233/JPD-212604"
"33662500","Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon","Jeon H, Bae CH, Lee Y, Kim HY, Kim S.","Brain Behav Immun. 2021 May;94:410-423. doi: 10.1016/j.bbi.2021.02.028. Epub 2021 Mar 2.","Jeon H","Brain Behav Immun","2021","2021/03/04","","","10.1016/j.bbi.2021.02.028"
"34413194","Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration","Wang C, Lau CY, Ma F, Zheng C.","Proc Natl Acad Sci U S A. 2021 Aug 24;118(34):e2106504118. doi: 10.1073/pnas.2106504118.","Wang C","Proc Natl Acad Sci U S A","2021","2021/08/20","PMC8403922","","10.1073/pnas.2106504118"
"34783227","Response of Escherichia coli to hydrogen nanobubbles: an in vitro evaluation using synchrotron infrared spectroscopy","Lu J, Zheng J, Wang Y, Cheng J, Li X, Hu J, Li B, Lü J.","J Zhejiang Univ Sci B. 2021 Nov 15;22(11):966-970. doi: 10.1631/jzus.B2100407.","Lu J","J Zhejiang Univ Sci B","2021","2021/11/16","PMC8593523","","10.1631/jzus.B2100407"
"34802221","From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease","Pellegrini C, D'Antongiovanni V, Ippolito C, Segnani C, Antonioli L, Fornai M, Bernardini N.","Eur J Histochem. 2021 Nov 22;65(s1):3278. doi: 10.4081/ejh.2021.3278.","Pellegrini C","Eur J Histochem","2021","2021/11/22","PMC8636839","","10.4081/ejh.2021.3278"
"34911958","Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease","van Kessel SP, Auvinen P, Scheperjans F, El Aidy S.","NPJ Parkinsons Dis. 2021 Dec 15;7(1):115. doi: 10.1038/s41531-021-00260-0.","van Kessel SP","NPJ Parkinsons Dis","2021","2021/12/16","PMC8674283","","10.1038/s41531-021-00260-0"
"33617267","Prebiotic Lactulose Ameliorates the Cognitive Deficit in Alzheimer's Disease Mouse Model through Macroautophagy and Chaperone-Mediated Autophagy Pathways","Lee YS, Lai DM, Huang HJ, Lee-Chen GJ, Chang CH, Hsieh-Li HM, Lee GC.","J Agric Food Chem. 2021 Mar 3;69(8):2422-2437. doi: 10.1021/acs.jafc.0c07327. Epub 2021 Feb 22.","Lee YS","J Agric Food Chem","2021","2021/02/22","","","10.1021/acs.jafc.0c07327"
"34025392","Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism","Nurrahma BA, Tsao SP, Wu CH, Yeh TH, Hsieh PS, Panunggal B, Huang HY.","Front Aging Neurosci. 2021 May 7;13:668775. doi: 10.3389/fnagi.2021.668775. eCollection 2021.","Nurrahma BA","Front Aging Neurosci","2021","2021/05/24","PMC8137830","","10.3389/fnagi.2021.668775"
"35127723","Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson's Disease Mouse Model Through Regulating Intestinal Microorganisms","Sun Z, Gu P, Xu H, Zhao W, Zhou Y, Zhou L, Zhang Z, Wang W, Han R, Chai X, An S.","Front Cell Dev Biol. 2022 Jan 20;9:808905. doi: 10.3389/fcell.2021.808905. eCollection 2021.","Sun Z","Front Cell Dev Biol","2022","2022/02/07","PMC8810651","","10.3389/fcell.2021.808905"
"34896331","Sodium butyrate attenuates rotenone-induced toxicity by activation of autophagy through epigenetically regulating PGC-1α expression in PC12 cells","Zhang Y, Xu S, Qian Y, He X, Mo C, Yang X, Xiao Q.","Brain Res. 2022 Feb 1;1776:147749. doi: 10.1016/j.brainres.2021.147749. Epub 2021 Dec 9.","Zhang Y","Brain Res","2022","2021/12/13","","","10.1016/j.brainres.2021.147749"
"34768765","Gastric Helicobacter suis Infection Partially Protects against Neurotoxicity in A 6-OHDA Parkinson's Disease Mouse Model","Berlamont H, Bruggeman A, Bauwens E, Vandendriessche C, Clarebout E, Xie J, De Bruyckere S, Van Imschoot G, Van Wonterghem E, Ducatelle R, Santens P, Smet A, Haesebrouck F, Vandenbroucke RE.","Int J Mol Sci. 2021 Oct 20;22(21):11328. doi: 10.3390/ijms222111328.","Berlamont H","Int J Mol Sci","2021","2021/11/13","PMC8582972","","10.3390/ijms222111328"
